Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (463) Complementary and Alternative Medicine (134) Clinical Cancer Research (139) Breast Cancer (331) Chemotherapy and Side Effects Management (128)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/91475, first published .
Efficacy and Safety of Shen-Ling-Lian-Xia Granule Combined With Neoadjuvant Chemotherapy in Patients With Triple-Negative Breast Cancer: Protocol for a Randomized, Double-Blind, Multicenter Clinical Trial

Efficacy and Safety of Shen-Ling-Lian-Xia Granule Combined With Neoadjuvant Chemotherapy in Patients With Triple-Negative Breast Cancer: Protocol for a Randomized, Double-Blind, Multicenter Clinical Trial

Efficacy and Safety of Shen-Ling-Lian-Xia Granule Combined With Neoadjuvant Chemotherapy in Patients With Triple-Negative Breast Cancer: Protocol for a Randomized, Double-Blind, Multicenter Clinical Trial

Authors of this article:

Yuanyuan Ren1, 2 Author Orcid Image ;   Shuai Yuan3 Author Orcid Image ;   Youyang Shi2 Author Orcid Image ;   Lichen Tang4 Author Orcid Image ;   Tian Li5 Author Orcid Image ;   Rui Yang6 Author Orcid Image ;   Kaigang Xie7 Author Orcid Image ;   Xiaoqing Zhang8 Author Orcid Image ;   Jue Chen9 Author Orcid Image ;   Jinhui Hu10 Author Orcid Image ;   Sheng Liu2 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.